This section covers a wide variety of medical and surgical supplies, as well as some DME-related supplies and accessories. Medicare generally covers DME-related supplies, accessories, maintenance, and repair under the prosthetic devices provision.

View All HCPCS Sections

• A9559

  Cobalt co-57 cyanocobalamin, oral, diagnostic, per study dose, up to 1 microcurie

• A9560

  Technetium tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuries

• A9561

  Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries

• A9562

  Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries

• A9563

  Sodium phosphate p-32, therapeutic, per millicurie

• A9564

  Chromic phosphate p-32 suspension, therapeutic, per millicurie

• A9566

  Technetium tc-99m fanolesomab, diagnostic, per study dose, up to 25 millicuries

• A9567

  Technetium tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuries

• A9568

  Technetium tc-99m arcitumomab, diagnostic, per study dose, up to 45 millicuries

• A9569

  Technetium tc-99m exametazime labeled autologous white blood cells, diagnostic, per study dose

• A9570

  Indium in-111 labeled autologous white blood cells, diagnostic, per study dose

• A9571

  Indium in-111 labeled autologous platelets, diagnostic, per study dose

• A9572

  Indium in-111 pentetreotide, diagnostic, per study dose, up to 6 millicuries

• A9573

  Injection, gadopiclenol, 1 ml

• A9575

  Injection, gadoterate meglumine, 0.1 ml

• A9576

  Injection, gadoteridol, (prohance multipack), per ml

• A9577

  Injection, gadobenate dimeglumine (multihance), per ml

• A9578

  Injection, gadobenate dimeglumine (multihance multipack), per ml

• A9579

  Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml

• A9580

  Sodium fluoride f-18, diagnostic, per study dose, up to 30 millicuries

• A9581

  Injection, gadoxetate disodium, 1 ml

• A9582

  Iodine i-123 iobenguane, diagnostic, per study dose, up to 15 millicuries

• A9583

  Injection, gadofosveset trisodium, 1 ml

• A9584

  Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries

• A9585

  Injection, gadobutrol, 0.1 ml

• A9586

  Florbetapir f18, diagnostic, per study dose, up to 10 millicuries

• A9587

  Gallium ga-68, dotatate, diagnostic, 0.1 millicurie

• A9588

  Fluciclovine f-18, diagnostic, 1 millicurie

• A9589

  Instillation, hexaminolevulinate hydrochloride, 100 mg

• A9590

  Iodine i-131, iobenguane, 1 millicurie

• A9591

  Fluoroestradiol f 18, diagnostic, 1 millicurie

• A9592

  Copper cu-64, dotatate, diagnostic, 1 millicurie

• A9593

  Gallium ga-68 psma-11, diagnostic, (ucsf), 1 millicurie

• A9594

  Gallium ga-68 psma-11, diagnostic, (ucla), 1 millicurie

• A9595

  Piflufolastat f-18, diagnostic, 1 millicurie

• A9596

  Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie

• A9597

  Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classified

• A9598

  Positron emission tomography radiopharmaceutical, diagnostic, for non-tumor identification, not otherwise classified

• A9599

  Radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified

• A9600

  Strontium sr-89 chloride, therapeutic, per millicurie

• A9601

  Flortaucipir f 18 injection, diagnostic, 1 millicurie

• A9602

  Fluorodopa f-18, diagnostic, per millicurie

• A9603

  Injection, pafolacianine, 0.1 mg

• A9604

  Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries

• A9606

  Radium ra-223 dichloride, therapeutic, per microcurie

• A9607

  Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie

• A9608

  Flotufolastat f 18, diagnostic, 1 millicurie

• A9609

  Fludeoxyglucose f18 up to 15 millicuries

• A9610

  Xenon xe-129 hyperpolarized gas, diagnostic, per study dose

• A9611

  Flurpiridaz f 18, diagnostic, 1 millicurie

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/4/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.